The Research and Development team at Gilead Sciences focuses on innovating and advancing biopharmaceutical therapies through a collaborative approach, encompassing drug discovery, clinical development, and product formulation. This multidisciplinary team integrates expertise in virology, oncology, biostatistics, and patient-focused research to drive pivotal studies and ensure the safety and efficacy of new treatments for critical diseases. Their efforts ultimately aim to enhance health outcomes and expand access to innovative therapies worldwide.
Anjali Srivastava
Associate Director, Quality Pr...
Han Ke
Associate Director, Project Ma...
Harry Jin
Associate Director - RWE Produ...
Hung-Wei Chih
Vp, Head Of Pre-pivotal Biolog...
Hussein Laljee
Head Of Benefit-risk Science &...
Jackson Egen
Vice President, Research Oncol...
Janet Dorling
Senior Vice President, Interco...
Joanna Koziara
Executive Director, Formulatio...
Kulin Varma
Associate Director Medical Wri...
Lynne Murray
Vp, Head Of UK Research, Site ...
Paramita Chakraborty
Principal Biostatistician
Paul Foley
Senior Vice President, Head Of...
Tomas Cihlar
Senior Vice President Of Resea...
Trudy Buckingham
Executive Director, Patient-fo...
Vahid Zia
Executive Director Of Product ...
Yi Piao
Director,scientific Innovation...
Zig Lang
Vice President, Head Of Intern...